Ganière Monteil C, Kergueris M F, Iooss P, Thomas L, Larousse C
Laboratoire de Pharmacologie Clinique, Centre Hospitalier Universitaire, Nantes, France.
J Pharm Biomed Anal. 1998 Jul;17(3):481-5. doi: 10.1016/s0731-7085(97)00215-x.
A method is described for determining amphotericin B in plasma using second-derivative spectrophotometry after deproteinization. The assay was based on the absorbance at 407.5 nm. The second-derivative spectrum recorded between 350 and 450 nm allowed identification of the analyte and showed absence of drug interference. Only bilirubin interfered at high concentration (> or = 50 mumol l-1. The linear concentration ranges were 0.05 -5.0 mg l-1 (r = 0.999, slope = 2.731, intercept = 0.008). Between-day CV < or = 9.7%, within-day CV < or = 5.5%, analytical recovery close to 100% were suitable for clinical investigations. This method provides better specificity than direct absorbance, is simpler and faster than a high performance liquid chromatography assay and can be used routinely by any laboratory possessing a spectrophotometer with a derivative accessory.
本文描述了一种使用去蛋白后二阶导数分光光度法测定血浆中两性霉素B的方法。该测定基于407.5nm处的吸光度。在350至450nm之间记录的二阶导数光谱可用于鉴定分析物,且显示无药物干扰。只有胆红素在高浓度(≥50μmol l-1)时会产生干扰。线性浓度范围为0.05 - 5.0mg l-1(r = 0.999,斜率 = 2.731,截距 = 0.008)。日间变异系数≤9.7%,日内变异系数≤5.5%,分析回收率接近100%,适用于临床研究。该方法比直接吸光度法具有更好的特异性,比高效液相色谱法更简单、更快,并且任何拥有带导数附件的分光光度计的实验室都可常规使用。